Literature DB >> 32044115

Advances in the Evolutionary Understanding of MHC Polymorphism.

Jacek Radwan1, Wiesław Babik2, Jim Kaufman3, Tobias L Lenz4, Jamie Winternitz5.   

Abstract

Proteins encoded by the classical major histocompatibility complex (MHC) genes incite the vertebrate adaptive immune response by presenting peptide antigens on the cell surface. Here, we review mechanisms explaining landmark features of these genes: extreme polymorphism, excess of nonsynonymous changes in peptide-binding domains, and long gene genealogies. Recent studies provide evidence that these features may arise due to pathogens evolving ways to evade immune response guided by the locally common MHC alleles. However, complexities of selection on MHC genes are simultaneously being revealed that need to be incorporated into existing theory. These include pathogen-driven selection for antigen-binding breadth and expansion of the MHC gene family, associated autoimmunity trade-offs, hitchhiking of deleterious mutations linked to the MHC, geographic subdivision, and adaptive introgression.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  MHC–KIR interaction; balancing selection; heterozygote advantage; major histocompatibility complex; negative frequency-dependent selection; polymorphism

Mesh:

Year:  2020        PMID: 32044115     DOI: 10.1016/j.tig.2020.01.008

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  54 in total

1.  Avian major histocompatibility complex copy number variation is associated with helminth richness.

Authors:  Piotr Minias; Jorge S Gutiérrez; Peter O Dunn
Journal:  Biol Lett       Date:  2020-07-08       Impact factor: 3.703

2.  HLA polymorphism and tapasin independence influence outcomes of HIV and dengue virus infection.

Authors:  Tiziana Di Pucchio; Rafick-Pierre Sekaly
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

Review 3.  Host-parasite co-evolution and its genomic signature.

Authors:  Dieter Ebert; Peter D Fields
Journal:  Nat Rev Genet       Date:  2020-08-28       Impact factor: 53.242

4.  Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity.

Authors:  Máté Manczinger; Balázs Koncz; Gergő Mihály Balogh; Benjamin Tamás Papp; Leó Asztalos; Lajos Kemény; Balázs Papp; Csaba Pál
Journal:  Nat Cancer       Date:  2021-07-08

5.  Intra-specific copy number variation of MHC class II genes in the Siamese fighting fish.

Authors:  Anson Tsz Chun Wong; Derek Kong Lam; Emily Shui Kei Poon; David Tsz Chung Chan; Simon Yung Wa Sin
Journal:  Immunogenetics       Date:  2022-03-01       Impact factor: 2.846

6.  Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion.

Authors:  Xutong Gong; Rachel Karchin
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

7.  Within-trio tests provide little support for post-copulatory selection on major histocompatibility complex haplotypes in a free-living population.

Authors:  W Huang; J M Pemberton
Journal:  Proc Biol Sci       Date:  2021-02-24       Impact factor: 5.349

8.  Spatiotemporal adaptive evolution of an MHC immune gene in a frog-fungus disease system.

Authors:  Alexa L Trujillo; Eric A Hoffman; C Guilherme Becker; Anna E Savage
Journal:  Heredity (Edinb)       Date:  2021-01-28       Impact factor: 3.821

9.  Genomics of response to porcine reproductive and respiratory syndrome virus in purebred and crossbred sows: antibody response and performance following natural infection vs. vaccination.

Authors:  Leticia P Sanglard; Felipe M W Hickmann; Yijian Huang; Kent A Gray; Daniel C L Linhares; Jack C M Dekkers; Megan C Niederwerder; Rohan L Fernando; Joseph Braccini Neto; Nick V L Serão
Journal:  J Anim Sci       Date:  2021-05-01       Impact factor: 3.159

10.  The genome of the Pyrenean desman and the effects of bottlenecks and inbreeding on the genomic landscape of an endangered species.

Authors:  Lídia Escoda; Jose Castresana
Journal:  Evol Appl       Date:  2021-05-29       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.